This question delves into predicting the year by which advancements in longevity research will allow for a significant extension in the lifespan of pet cats. With a current average lifespan of 12-15 years for domestic cats, this market aims to determine when pets can realistically expect to live an additional 10 years. It’s important to note that historically, scientific breakthroughs in animal health often precede similar advancements in human medicine.
Obligatory cat tax below.
1,000People are also trading
Two data points for the cat clock. The first regulator to accept lifespan extension as a drug indication did it for dogs, not cats: the FDA's veterinary center accepted Loyal's effectiveness sections for LOY-001 (November 2023) and LOY-002 (February 2025). For cats the nearest thing is FeliAIM, the AIM-protein drug for feline chronic kidney disease filed with Japan's agriculture ministry on 24 April 2026 after a small study (11 treated versus 15 untreated cats, one-year survival about 80% versus 20%); review takes 6 to 12 months, and it is a disease drug rather than an aging drug. Then scale: ten extra years on a 12-to-15-year lifespan is a 70 to 80% extension, while the largest replicated drug effect on median lifespan in mice is roughly a quarter (rapamycin in the NIA testing program, 23 to 26%). Which species gets the first approved lifespan drug (mine): /w0lph/which-species-will-get-the-first-re
I'm reopening this for continued trading until the answer is established; if that's a mistake @QianchengXiong please let me know!
Creator appears inactive. If this ends up being a mod resolution, I currently plan to interpret it as being primarily about the life extension as measured, and mostly not about whether "longevity research" had an impact, since I expect that to be very hard to judge.